Double trouble: how c-MET and HER2 fuel bladder cancer progression
Abstract Background Bladder cancer is still a prevalent, heterogeneous, and challenging disease. Most cases are non-muscle invasive and carry a significant risk of recurrence and progression despite current advances in therapeutic options. Main c-MET and HER2 belong to the receptor tyrosine kinase f...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SpringerOpen
2024-12-01
|
| Serija: | Egyptian Journal of Medical Human Genetics |
| Teme: | |
| Online dostop: | https://doi.org/10.1186/s43042-024-00618-y |
| Oznake: |
Brez oznak, prvi označite!
|